# IMU-838 trials for PSC and Coronavirus **URL:** \ **Category:** Life with Primary Sclerosing Cholangitis\ **Created:** [May 14, 2020, 11:53am UTC](https://forum.livingwithpsc.org/t/imu-838-trials-for-psc-and-coronavirus/3882 "2020-05-14T11:53:33Z")\ **Posts on this page:** 2\ **Page:** 1
**Author:** ![Ted](https://sea1.discourse-cdn.com/flex019/user_avatar/forum.livingwithpsc.org/ted/32/381_2.png) [@Ted](https://forum.livingwithpsc.org/u/Ted)\ **Post date:** [May 14, 2020, 11:53am UTC](https://forum.livingwithpsc.org/t/imu-838-trials-for-psc-and-coronavirus/3882/1 "2020-05-14T11:53:33Z")
interesting news, though very early of course. “ Phase 2 Clinical Trial of its Selective Oral DHODH Inhibitor, IMU-838, in COVID-19 Patients… Furthermore, Immunic’s collaboration partner, the Mayo Clinic, has started an investigator-sponsored proof-of-concept clinical trial testing IMU-838 activity in patients with primary sclerosing cholangitis.” I wouldn’t mind to have one treatment to cure both PSC and Coronavirus… > **[Immunic, Inc. Receives First Regulatory Approval from German Health Authority...](https://www.immunic-therapeutics.com/2020/05/13/immunic-inc-receives-first-regulatory-approval-from-german-health-authority-bfarm-to-initiate-a-phase-2-clinical-trial-of-its-selective-oral-dhodh-inhibitor-imu-838-in-covid-19-patients/)** > > Immunic is a specialist in selective oral drugs in immunology and focused on developing novel oral therapies with best-in-class potential for chronic inflammatory and autoimmune diseases. ---
**Author:** ![JeffDC1](https://sea1.discourse-cdn.com/flex019/user_avatar/forum.livingwithpsc.org/jeffdc1/32/402_2.png) [@JeffDC1](https://forum.livingwithpsc.org/u/JeffDC1)\ **Post date:** [May 18, 2020, 1:42am UTC](https://forum.livingwithpsc.org/t/imu-838-trials-for-psc-and-coronavirus/3882/2 "2020-05-18T01:42:43Z")
Let’s cross our fingers.